These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16159096)

  • 41. [Treatment of acute stroke with systemic thrombolysis--benefit or risk?].
    Lyrer P; Fluri F
    Praxis (Bern 1994); 2001 Feb; 90(7):253-6. PubMed ID: 11256225
    [No Abstract]   [Full Text] [Related]  

  • 42. The Interventional Management of Stroke (IMS) II Study.
    IMS II Trial Investigators
    Stroke; 2007 Jul; 38(7):2127-35. PubMed ID: 17525387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Additional endovascular therapy in patients with acute ischemic stroke who are nonresponsive to intravenous tissue plasminogen activator: usefulness of magnetic resonance angiography-diffusion mismatch.
    Dembo T; Deguchi I; Fukuoka T; Nagoya H; Maruyama H; Kato Y; Horiuchi Y; Ohe Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1056-63. PubMed ID: 22902147
    [TBL] [Abstract][Full Text] [Related]  

  • 44. M1 susceptibility vessel sign on T2* as a strong predictor for no early recanalization after IV-t-PA in acute ischemic stroke.
    Kimura K; Iguchi Y; Shibazaki K; Watanabe M; Iwanaga T; Aoki J
    Stroke; 2009 Sep; 40(9):3130-2. PubMed ID: 19556532
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tissue plasminogen activator for acute ischemic stroke: calculation of dose based on estimated patient weight can increase the risk of cerebral bleeding.
    García-Pastor A; Díaz-Otero F; Funes-Molina C; Benito-Conde B; Grandes-Velasco S; Sobrino-García P; Vázquez-Alén P; Fernández-Bullido Y; Villanueva-Osorio JA; Gil-Núñez A
    J Thromb Thrombolysis; 2015 Oct; 40(3):347-52. PubMed ID: 25995103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The safety of intravenous thrombolysis for ischemic stroke in patients with pre-existing cerebral aneurysms: a case series and review of the literature.
    Edwards NJ; Kamel H; Josephson SA
    Stroke; 2012 Feb; 43(2):412-6. PubMed ID: 22156701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulmonary embolism in a stroke patient after systemic thrombolysis: clinical decisions and literature review.
    Pilato F; Calandrelli R; Profice P; Della Marca G; Broccolini A; Bello G; Bocci MG; Distefano M; Colosimo C; Rossini PM
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e667-70. PubMed ID: 23849749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Thrombolytic treatment in stroke in patients with intracardiac thrombus: presentation of one case].
    Segura T; Herrera M; Garcia-Muñozguren S; Zorita MD
    Neurologia; 2005 Apr; 20(3):149-52. PubMed ID: 15815951
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Downstream Migration and Fragmentation of a Spontaneous Calcific Embolus after Thrombolysis in a Patient with Ischemic Stroke.
    López-Cuevas R; Lago A; Tembl JI
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):e165-6. PubMed ID: 27499273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
    Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
    J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and feasibility of intravenous rt-PA in the Emergency Department without a neurologist-based stroke unit: an observational study.
    Tampieri A; Giovannini E; Rusconi AM; Cristoni L; Bendanti D; Cenni P; Lenzi T
    Intern Emerg Med; 2015 Mar; 10(2):181-92. PubMed ID: 25430677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
    Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous thrombolysis for patients with reverse magnetic resonance angiography and diffusion-weighted imaging mismatch: SAMURAI and NCVC rt-PA Registries.
    Sakamoto Y; Koga M; Kimura K; Nagatsuka K; Okuda S; Kario K; Hasegawa Y; Okada Y; Yamagami H; Furui E; Nakagawara J; Shiokawa Y; Okata T; Kobayashi J; Tanaka E; Minematsu K; Toyoda K
    Eur J Neurol; 2014 Mar; 21(3):419-26. PubMed ID: 24261412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The combination of elevated BNP and AF as a predictor of no early recanalization after IV-t-PA in acute ischemic stroke.
    Kimura K; Shibazaki K; Iguchi Y; Aoki J; Sakai K; Sakamoto Y; Kobayashi K
    J Neurol Sci; 2010 Mar; 290(1-2):37-40. PubMed ID: 20015516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stroke Mimics and Acute Stroke Evaluation: Clinical Differentiation and Complications after Intravenous Tissue Plasminogen Activator.
    Nguyen PL; Chang JJ
    J Emerg Med; 2015 Aug; 49(2):244-52. PubMed ID: 25802155
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Significance of magnetic resonance angiography-diffusion weighted imaging mismatch in hyperacute cerebral infarction.
    Deguchi I; Takeda H; Furuya D; Dembo T; Nagoya H; Kato Y; Ito Y; Fukuoka T; Maruyama H; Tanahashi N
    J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):108-13. PubMed ID: 20851627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The susceptibility vessel sign at the proximal M1: a strong predictor for poor outcome after intravenous thrombolysis.
    Aoki J; Kimura K; Shibazaki K; Saji N; Uemura J; Sakamoto Y; Nagai K
    J Neurol Sci; 2015 Jan; 348(1-2):195-200. PubMed ID: 25529923
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment outcomes of tissue plasminogen activator infusion for branch atheromatous disease.
    Deguchi I; Hayashi T; Kato Y; Nagoya H; Ohe Y; Fukuoka T; Maruyama H; Horiuchi Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e168-72. PubMed ID: 23246192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of the approval of intravenous recombinant tissue plasminogen activator therapy on the processes of acute stroke management in Japan: the Stroke Unit Multicenter Observational (SUMO) Study.
    Sato S; Uehara T; Toyoda K; Yasui N; Hata T; Ueda T; Okada Y; Toyota A; Hasegawa Y; Naritomi H; Minematsu K;
    Stroke; 2009 Jan; 40(1):30-4. PubMed ID: 18948604
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversal of locked-in syndrome with anticoagulation, induced hypertension, and intravenous t-PA.
    Janjua N; Wartenberg KE; Meyers PM; Mayer SA
    Neurocrit Care; 2005; 2(3):296-9. PubMed ID: 16159079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.